Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780

被引:0
|
作者
Hyder, SM
Chiappetta, C
Murthy, L
Stancel, GM
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT OBSTET GYNECOL & REPROD SCI,HOUSTON,TX 77225
[2] BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Estrogen-stimulated cell proliferation is thought to be mediated by the induction of growth-regulatory factors. Abnormal regulation of such factors may be associated with tumorigenesis. Two such factors, vascular endothelial growth factor and c-fos, are rapidly induced in the uterus by estrogens. We show that the induction of these transcripts by 17 beta-estradiol or tamoxifen is selectively blocked by the pure antiestrogen ICI 182,780 in a dose-dependent manner. This indicates that induction of the two genes requires different Levels of estrogen receptor or that their induction occurs by different mechanisms. This suggests that selective dose-dependent antagonism of estrogen-dependent transcription may be possible in target tissues and tumors.
引用
收藏
页码:2547 / 2549
页数:3
相关论文
共 50 条
  • [1] ICI 182,780 (Faslodex™) -: Development of a novel, "pure" antiestrogen
    Howell, A
    Osborne, CK
    Morris, C
    Wakeling, AE
    CANCER, 2000, 89 (04) : 817 - 825
  • [2] Effects of the antiestrogen fulvestrant (ICI 182,780) on gene expression of the rat efferent ductules
    Yasuhara, Fabiana
    Oliveira Gomes, Gisele Renata
    Siu, Erica Rosanna
    Suenaga, Claudia Igushi
    Marostica, Elisabeth
    Porto, Catarina Segreti
    Magalhaes Lazari, Maria Fatima
    BIOLOGY OF REPRODUCTION, 2008, 79 (03) : 432 - 441
  • [3] The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription
    Nawaz, Z
    Stancel, GM
    Hyder, SM
    CANCER RESEARCH, 1999, 59 (02) : 372 - 376
  • [4] Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?
    Zand, RSR
    Grass, L
    Magklara, A
    Jenkins, DJA
    Diamandis, EP
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 60 (01) : 1 - 8
  • [5] Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?
    Rachel S. Rosenberg Zand
    Rachel S. Rosenberg Zand
    Linda Grass
    Angeliki Magklara
    Angeliki Magklara
    David J.A. Jenkins
    Eleftherios P. Diamandis
    Eleftherios P. Diamandis
    Breast Cancer Research and Treatment, 2000, 60 : 1 - 8
  • [6] A ''pure'' antiestrogen (ICI 182,780) inhibits endometrial development in the neonatal pig.
    Wiley, AA
    Tarleton, BJ
    Bartol, FF
    BIOLOGY OF REPRODUCTION, 1996, 54 : 251 - 251
  • [7] The antiestrogen ICI 182,780 inhibits proliferation of human breast cancer cells by interfering with multiple, sequential estrogen-regulated processes required for cell cycle completion
    Cicatiello, L
    Addeo, R
    Altucci, L
    Petrizzi, VB
    Boccia, V
    Cancemi, M
    Germano, D
    Pacilio, C
    Salzano, S
    Bresciani, F
    Weisz, A
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 165 (1-2) : 199 - 209
  • [8] Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780
    Hyder, SM
    Stancel, GM
    CANCER LETTERS, 2002, 181 (01) : 47 - 53
  • [9] Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780
    Chan, TW
    Pollak, M
    Huynh, H
    CLINICAL CANCER RESEARCH, 2001, 7 (08) : 2545 - 2554
  • [10] Prooxidant property of antiestrogen ICI 182,780: Physiological relevance.
    Santanam, N
    Parthasarathy, S
    FREE RADICAL BIOLOGY AND MEDICINE, 1999, 27 : S98 - S98